Avalon Trust’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.6K Hold
60
﹤0.01% 328
2026
Q1
$33.7K Sell
60
-90
-60% -$57.7K ﹤0.01% 323
2025
Q4
$101K Hold
150
0.01% 201
2025
Q3
$95.8K Buy
150
+100
+200% +$60.7K 0.01% 237
2025
Q2
$26.8K Hold
50
﹤0.01% 308
2025
Q1
$21K Hold
50
﹤0.01% 327
2024
Q4
$20.7K Hold
50
﹤0.01% 288
2024
Q3
$25.2K Hold
50
﹤0.01% 253
2024
Q2
$24.4K Hold
50
﹤0.01% 254
2024
Q1
$27K Hold
50
﹤0.01% 253
2023
Q4
$27.8K Hold
50
﹤0.01% 245
2023
Q3
$21.9K Hold
50
﹤0.01% 227
2023
Q2
$25.1K Hold
50
﹤0.01% 243
2023
Q1
$25K Buy
+50
New +$23.9K ﹤0.01% 232

Other funds holding IDXX

Avalon Trust's IDXX Position: Q2 2026 in Review

Avalon Trust held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 60 shares worth $31.6K. The position accounts for ﹤0.01% of the portfolio, ranked #328.

Avalon Trust first reported a position in IDXX in Q1 2023 and has held it in 14 quarters since. The position peaked at $101K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Avalon Trust held 60 shares of Idexx Laboratories worth $31.6K as of Q2 2026.
  • Avalon Trust left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Avalon Trust's portfolio in Q2 2026, its #328 holding.
  • Avalon Trust first reported a position in Idexx Laboratories in Q1 2023 and has held it in 14 quarters since.
  • Avalon Trust's Idexx Laboratories position peaked at $101K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Avalon Trust's 13F filing for Q2 2026, filed 6 Aug 2026.